Machine Learning Approaches for Compound-Target Interaction Prediction: A Review. [PDF]
Zhang J +6 more
europepmc +1 more source
Artificial intelligence in drug discovery from advanced molecular representation to pipeline applications. [PDF]
Zhou X, Tao W.
europepmc +1 more source
A Risk-Tiered Validation Framework for Artificial Intelligence in Drug Discovery: From Reproducibility to Clinical Translation. [PDF]
Niazi SK.
europepmc +1 more source
Target-aware molecule SMILES generation using a large language model with retrieval-augmented generation, multi-turn memory, and a predictive model. [PDF]
Karabowicz P +3 more
europepmc +1 more source
Explainable Artificial Intelligence (xAI) for 5-HT<sub>2A</sub> Receptor Binding Affinity of New Psychoactive Substances. [PDF]
Schöning V +5 more
europepmc +1 more source
Related searches:
Breaking the barriers of data scarcity in drug–target affinity prediction
Briefings in Bioinformatics, 2023Abstract Accurate prediction of drug–target affinity (DTA) is of vital importance in early-stage drug discovery, facilitating the identification of drugs that can effectively interact with specific targets and regulate their activities. While wet experiments remain the most reliable method, they are time-consuming and resource-intensive,
Qizhi Pei, Lijun Wu, Jinhua Zhu
exaly +4 more sources
Modality-DTA: Multimodality Fusion Strategy for Drug–Target Affinity Prediction
IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2023Prediction of the drug-target affinity (DTA) plays an important role in drug discovery. Existing deep learning methods for DTA prediction typically leverage a single modality, namely simplified molecular input line entry specification (SMILES) or amino acid sequence to learn representations.
Xixi Yang +2 more
exaly +4 more sources

